Search for: "In Re Medical Review Panel" Results 421 - 440 of 893
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Dec 2017, 1:31 pm by Schachtman
D.C. 1999). 3 See In re Breast Implant Cases, 942 F. [read post]
4 Apr 2023, 11:55 am by Richard Reibstein Esq.
  Many have sought to do so by resorting to a process such as IC Diagnostics (TM), which enhances IC compliance by restructuring, re-documenting, and/or re-implementing IC relationships in a customized and sustainable manner in view of applicable law, including A.B 5. [read post]
12 May 2022, 6:04 pm by The Work Injury Site admin
If you do have some concerns that you’re pre injury average weekly earnings haven’t been calculated accurately, then it would be a good idea to seek WorkCover legal advice and have the insurers calculations reviewed. [read post]
9 Feb 2009, 5:40 pm
This panel is geared towards students who are interested in learning more about careers and opportunities in the dynamic field of Health Law. [read post]
17 Jun 2021, 12:29 pm by admin
The expert panel’s unanimous rejection of the plaintiffs’ cla [read post]
15 Apr 2007, 5:48 am
"It's more like having acomplicated medical problem and you go get several opinions. [read post]
7 Feb 2011, 2:58 am by Marie Louise
(Patents Post Grant Blog) US Patents – Decisions CAFC panel disagrees on proper role of specification in claim construction: Arlington v. [read post]
26 Dec 2017, 9:30 pm by Series of Essays
Medical professionals prescribe opioids to treat pain from injuries, surgeries, and chronic diseases. [read post]
8 Mar 2022, 8:34 pm by The Work Injury Site admin
If the insurer stops your payment because the believe you have a capacity, you can have the decision reviewed and challenged. [read post]
9 Mar 2012, 10:54 am by Max Kennerly, Esq.
In fact, when the RE-LY study came out, there was already concern among the FDA advisory panel members that the drug didn’t really offer an improvement over warfarin in preventing stroke in patients with atrial fibrillation, but rather offered just a different balance of the risk of bleeding versus the risk of stroke: “The 110-mg dose, while associated with reduced bleeding, had a 12% higher incidence of ischemic stroke,” said… [read post]
12 Dec 2017, 11:02 am
Report on IPKat-BLACA panel discussion |  US patent litigation on the move again following In re Cray | Does the doctrine of equivalents apply to novelty? [read post]
20 Jul 2018, 12:30 pm by John K. Ross
Dissenting from denial of review, Judge Rosenbaum likens the precedent the panel relied upon to "an Edsel with a missing engine. [read post]
23 Sep 2018, 11:59 pm by Jennifer McGrath
  The process requires notification to the prosecution of eligibility and mandates review by the prosecution no later than July 1, 2020. [read post]
23 Sep 2018, 11:59 pm by Jennifer McGrath
  The process requires notification to the prosecution of eligibility and mandates review by the prosecution no later than July 1, 2020. [read post]
23 Sep 2018, 11:59 pm by Jennifer McGrath
  The process requires notification to the prosecution of eligibility and mandates review by the prosecution no later than July 1, 2020. [read post]
2 Mar 2021, 6:30 am by Michael B. Stack
” Utilization review services – The review of medical care and prescription drug use is a key driver in costs. [read post]
22 Apr 2018, 9:00 am by Michael H Cohen
” FDA has established classifications for approximately 1,700 different generic types of devices and grouped them into 16 medical specialties referred to as panels. [read post]
18 Jan 2012, 4:10 am by Max Kennerly, Esq.
Most of those opinions (the bulk are available here) are not even a year old, and they are all from the District Court, which means they haven’t even been reviewed on appeal. [read post]